Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome
Referencias
Additional references
Abizaid A, Costa JR. New drug‐eluting stents: an overview on biodegradable and polymer‐free next‐generation stent systems. Circulation. Cardiovascular Interventions 2010;3(4):384‐93.
American College of Emergency Physicians (ACEP), Society for Cardiovascular Angiography and Interventions, O'Gara PT, Kushner FG, Ascheim DD, Casey DE, et al. 2013 ACCF/AHA guideline for the management of ST‐elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 2013;61(4):e78‐140.
Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA/ACC guideline for the management of patients with non‐ST‐elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;130(25):2354‐94.
Baim DS, Grossman W. Complications of cardiac catheterization. In: Baim DS, Grossman W editor(s). Cardiac Catheterization, Angiography and Intervention. Williams & Wilkins, 1996:17.
Braunwald E. Unstable angina: an etiologic approach to management. Circulation 1998;98(21):2219‐22.
Breall JA, Aroesty JM, Simons M. Overview of the non‐acute management of unstable angina and non‐ST elevation myocardial infarction. www.uptodate.com/contents/overview‐of‐the‐non‐acute‐management‐of‐unstable‐angina‐and‐non‐st‐elevation‐myocardial‐infarction (accessed 19 November 2015).
Brieger D, Fox KA, Fitzgerald G, Eagle KA, Budaj A, Avezum A, et al. Predicting freedom from clinical events in non‐ST‐elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart 2009;95(11):888‐94.
Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology 2008;61(8):763‐9.
Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta‐analyses may be inconclusive. Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology 2009;38(1):287‐98.
Cantor WJ, Lazzam C, Cohen EA, Bowman KA, Dolman S, Mackie K, et al. Failed coronary stent deployment. American Heart Journal 1998;136(6):1088‐95.
Cantor WJ, Puley G, Natarajan MK, Dzavik V, Madan M, Fry A, et al. Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction‐‐the RADIAL‐AMI pilot randomized trial. American Heart Journal 2005;150(3):543‐9. [PUBMED: 16169338]
Chen W, Habraken TC, Hennink WE, Kok RJ. Polymer‐free drug‐eluting stents: an overview of coating strategies and comparison with polymer‐coated drug‐eluting stents. Bioconjugate Chemistry 2015;26(7):1277‐88. [PUBMED: 26041505]
Cooper R, Cutler J, Desvigne‐Nickens P, Fortmann SP, Friedman L, Havlik R, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation2000; Vol. 102, issue 25:3137‐47. [PUBMED: 11120707]
Copenhagen Trial Unit (CTU), Centre for Clinical Intervention Research. Trial Sequential Analysis (TSA) (www.ctu.dk/tsa). Copenhagen, Denmark, 2011.
Cutlip DE, Chauhan MS, Baim DS, Ho KK, Popma JJ, Carrozza JP, et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. Journal of the American College of Cardiology 2002;40(12):2082‐9.
Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115(17):2344‐51. [PUBMED: 17470709]
Dangas G, Kuepper F. Restenosis: Repeat Narrowing of a Coronary Artery. Circulation 2002;105(22):2586.
De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, et al. Drug‐eluting vs bare‐metal stents in primary angioplasty: a pooled patient‐level meta‐analysis of randomized trials. Archives of Internal Medicine 2012;172(8):611‐21.
Degertekin M, Regar E, Tanabe K, Lee CH, Serruys PW. Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease. Minerva Cardioangiologica 2002;50(5):405‐18. [PUBMED: 12384623]
Demets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341‐50. [PUBMED: 3616287]
DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88. [PUBMED: 3802833]
Dudas K, Björck L, Jernberg T, Lappas G, Wallentin L, Rosengren A. Differences between acute myocardial infarction and unstable angina: a longitudinal cohort study reporting findings from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS‐HIA). BMJ Open 2013;3(1):e002155.
Düber C, Jungbluth A, Rumpelt HJ, Erbel R, Meyer J, Thoenes W. Morphology of the coronary arteries after combined thrombolysis and percutaneous transluminal coronary angioplasty for acute myocardial infarction. The American Journal of Cardiology 1986;58(9):698‐703.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34.
Erbel R, Haude M, Höpp HW, Franzen D, Rupprecht HJ, Heublein B, et al. Coronary‐artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group. The New England Journal of Medicine 1998;339(23):1672‐8.
Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, et al. Randomized, double‐blind, multicenter study of the Endeavor zotarolimus‐eluting phosphorylcholine‐encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation 2006;114(8):798‐806. [PUBMED: 16908773]
Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013;381(9867):639‐50.
Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary‐stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. The New England Journal of Medicine 1994;331(8):496‐501. [PUBMED: 8041414]
Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. The American Journal of Cardiology1983; Vol. 51, issue 3:606. [PUBMED: 6823874]
Gluud LL. Bias in clinical intervention research. American Journal of Epidemiology 2006;163(6):493‐501.
Greenhalgh J, Hockenhull J, Rao N, Dundar Y, Dickson RC, Bagust A. Drug‐eluting stents versus bare metal stents for angina or acute coronary syndromes. Cochrane Database of Systematic Reviews 2010, Issue 5. [DOI: 10.1002/14651858.CD004587.pub3]
Grüntzig A. Transluminal dilatation of coronary‐artery stenosis. Lancet 1978;1(8058):263. [PUBMED: 74678]
Grüntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary‐artery stenosis: percutaneous transluminal coronary angioplasty. The New England Journal of Medicine 1979;301(2):61‐8. [PUBMED: 449946]
Gupta M, Chang WC, Van de Werf F, Granger CB, Midodzi W, Barbash G, et al. International differences in in‐hospital revascularization and outcomes following acute myocardial infarction. European Heart Journal 2003;24(18):1640‐50.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck‐Ytter Y, Alonso‐Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924‐6. [PUBMED: 18436948]
Hamon M, Rasmussen LH, Manoukian SV, Cequier A, Lincoff MA, Rupprecht HJ, et al. Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trial. EuroIntervention 2009;5(1):115‐20. [PUBMED: 19577992]
Harbord RM, Egger M, Sterne JA. A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints. Statistics in Medicine 2006;25(20):3443‐57. [PUBMED: 16345038]
Haude M, Erbel R, Erne P, Verheye S, Degen H, Böse D, et al. Safety and performance of the drug‐eluting absorbable metal scaffold (DREAMS) in patients with de‐novo coronary lesions: 12 month results of the prospective, multicentre, first‐in‐man BIOSOLVE‐I trial. Lancet 2013;381(9869):836‐44.
Haude M, Ince H, Abizaid A, Toelg R, Lemos PA, von Birgelen C, et al. Safety and performance of the second‐generation drug‐eluting absorbable metal scaff old in patients with de‐novo coronary artery lesions (BIOSOLVE‐II): 6 month results of a prospective, multicentre, non‐randomised, first‐in‐man trial. Lancet 2016;387(10013):31‐9.
Hicks KA, Hung JHM, Mahaffey KW, Mehran R, Nissen SE, Stockbridge NL, et al. Standardized definitions for end point events in cardiovascular trials. www.clinpage.com/images/uploads/endpoint‐defs_11‐16‐2010.pdf (accessed 24 June 2016).
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21(11):1539‐58.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60.
Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration.
Higgins JP, Whitehead A, Simmonds M. Sequential methods for random‐effects meta‐analysis. Statistics in Medicine 2011;30(9):903‐21. [PUBMED: 21472757]
Hoenig MR, Aroney CN, Scott IA. Early invasive versus conservative strategies for unstable angina and non‐ST elevation myocardial infarction in the stent era. Cochrane Database of Systematic Reviews 2010, Issue 3. [DOI: 10.1002/14651858.CD004815.pub4]
Holmes DR, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, et al. Analysis of 1‐year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus‐eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004;109(5):634‐40. [PUBMED: 14769686]
Hróbjartsson A, Emanuelsson F, Skou Thomsen AS, Hilden J, Brorson S. Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub‐studies. International Journal of Epidemiology 2014;43(4):1272‐83.
International Conference on Harmonisation Expert Working Group (ICH‐EWG). International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice in CFR & ICH Guidelines. Vol. 1, Pennsylvania, USA: Barnett International/PAREXEL, 1997.
Jakobsen JC, Wetterslev J, Winkel P, Lange T, Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta‐analytic methods. BMC Medical Research Methodology 2014;14:120. [PUBMED: 25416419]
Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, et al. Analysis of 14 trials comparing sirolimus‐eluting stents with bare‐metal stents. The New England Journal of Medicine 2007;356(10):1030‐9. [PUBMED: 17296823]
Keus F, Wetterslev J, Gluud C, van Laarhoven CJ. Evidence at a glance: error matrix approach for overviewing available evidence. BMC Medical Research Methodology2010; Vol. 10:90.
Kip KE, Hollabaugh K, Marroquin OC, Williams DO. The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. Journal of the American College of Cardiology 2008;51(7):701‐7. [PUBMED: 18279733]
Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine 2001;135(11):982‐9.
Lee MS, Shah AP, Aragon J, Jamali A, Dohad S, Kar S, et al. Drug‐eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheterization and Cardiovascular Interventions 2005;66(4):507‐11. [PUBMED: 16270361]
Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration.
Levin T, Aroesty JM. Stable ischemic heart disease: indications for revascularization. www.uptodate.com/contents/stable‐ischemic‐heart‐disease‐indications‐for‐revascularization (accessed 10 September 2015).
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011;124(23):2574‐609. [PUBMED: 22064598]
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST‐elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST‐Elevation myocardial infarction. Journal of the American College of Cardiology 2016;67(10):1235‐50.
Lloyd‐Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Executive summary: heart disease and stroke statistics‐‐2010 update: a report from the American Heart Association. Circulation 2010;121(7):948‐54. [PUBMED: 20177011]
Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2]
Macaya C, Serruys PW, Ruygrok P, Suryapranata H, Mast G, Klugmann S, et al. Continued benefit of coronary stenting versus balloon angioplasty: one‐year clinical follow‐up of Benestent trial. Benestent Study Group. Journal of the American College of Cardiology 1996;27(2):255‐61. [PUBMED: 8557891]
Maddox TM, Reid KJ, Rumsfeld JS, Spertus JA. One‐year health status outcomes of unstable angina versus myocardial infarction: a prospective, observational cohort study of ACS survivors. BMC Cardiovascular Disorders 2007;7:28.
Meyer J, Schmitz H, Erbel R, Kiesslich T, Böcker‐Josephs B, Krebs W, et al. Treatment of unstable angina pectoris with percutaneous transluminal coronary angioplasty (PTCA). Catheterization and Cardiovascular Diagnosis 1981;7(4):361‐71.
Meyer J, Merx W, Dörr R, Lambertz H, Bethge C, Effert S. Successful treatment of acute myocardial infarction shock by combined percutaneous transluminal coronary recanalization (PTCR) and percutaneous transluminal coronary angioplasty (PTCA). American Heart Journal 1982;103(1):132‐4.
Meyer J, Merx W, Schmitz H, Erbel R, Kiesslich T, Dörr R, et al. Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation 1982;66(5):905‐13.
Meyer J, Schmitz HJ, Kiesslich T, Erbel R, Krebs W, Schulz W, et al. Percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris: Analysis of early and late results. American Heart Journal 1983;106(5 Pt 1):973‐80.
Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet 1998;352(9128):609‐13.
Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus‐eluting stent with a standard stent for coronary revascularization. The New England Journal of Medicine 2002;346(23):1773‐80. [PUBMED: 12050336]
Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus‐eluting stents versus standard stents in patients with stenosis in a native coronary artery. The New England Journal of Medicine 2003;349(14):1315‐23. [PUBMED: 14523139]
NICE (National Institute for Health and Care Excellence). Drug‐eluting stents for the treatment of coronary artery disease. www.nice.org.uk/guidance/ta152?unlid=1066690929201610722145. Accessed prior to 12 Feburary 2016.
Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. European Heart Journal 2014;35(42):2929. [PUBMED: 25139896]
Pocock SJ, Clayton TC, Stone GW. Design of major randomized trials: part 3 of a 4‐part series on statistics for clinical trials. Journal of the American College of Cardiology 2015;66(24):2757‐66.
Pogue JM, Yusuf S. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta‐analysis. Controlled Clinical Trials 1997;18(6):580‐93; discussion 661‐6. [PUBMED: 9408720]
Pohjola‐Sintonen S, Muller JE, Stone PH, Willich SN, Antman EM, Davis VG, et al. Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. American Heart Journal 1989;117(4):809‐18.
Puel J, Juilliere Y, Bertrand ME, Rickards AF, Sigwart U, Serruys PW. Early and late assessment of stenosis geometry after coronary arterial stenting. The American Journal of Cardiology 1988;61(8):546‐53.
Puricel S, Arroyo D, Corpataux N, Baeriswyl G, Lehmann S, Kallinikou Z, et al. Comparison of everolimus‐ and biolimus‐eluting coronary stents with everolimus‐eluting bioresorbable vascular scaffolds. Journal of the American College of Cardiology 2015;65(8):791‐801.
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Ringqvist I, Fisher LD, Mock M, Davis KB, Wedel H, Chaitman BR, et al. Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). The Journal of Clinical Investigation 1983;71(6):1854‐66. [PUBMED: 6863543]
Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST‐segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST‐Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal 2016;37(3):267‐315.
Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics‐‐2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117(4):e25‐146. [PUBMED: 18086926]
Roukoz H, Bavry AA, Sarkees ML, Mood GR, Kumbhani DJ, Rabbat MG, et al. Comprehensive meta‐analysis on drug‐eluting stents versus bare‐metal stents during extended follow‐up. The American Journal of Medicine 2009;122(6):581. [PUBMED: 19486720]
Ruiz‐Bailén M, Rucabado‐Aguilar L, Castillo‐Rivera AM, Expósito‐Ruiz M, Morante‐Valle A, Rodríguez‐García JJ, et al. Cardiogenic shock in acute coronary syndrome in the Spanish population. Medical Science Monitor 2008;14(11):PH46‐57.
Rücker G, Schwarzer G, Carpenter J. Arcsine test for publication bias in meta‐analyses with binary outcomes. Statistics in Medicine 2008;27(5):746‐63. [PUBMED: 17592831]
Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine 2012;157(6):429‐38.
Savović J, Jones H, Altman D, Harris R, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta‐epidemiological studies. Health Technology Assesment 2012;16(35):1‐82.
Schmidt M, Jacobsen JB, Lash TL, Bøtker HE, Sørensen HT. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ 2012;344:e356. [PUBMED: 22279115]
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408‐12.
Seizer A. On the limitation of therapeutic intervention trials in ischemic heart disease: a clinican's viewpoint. The American Journal of Cardiology 1982;49(1):252‐5.
Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon‐expandable‐stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. The New England Journal of Medicine 1994;331(8):489‐95. [PUBMED: 8041413]
Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C, et al. Randomised comparison of implantation of heparin‐coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998;352(9129):673‐81. [PUBMED: 9728982]
Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE, et al. Comparison of zotarolimus‐eluting and everolimus‐eluting coronary stents. The New England Journal of Medicine 2010;363(2):136‐46. [PUBMED: 20554978]
Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1(2):219‐27. [PUBMED: 19758907]
Stankovic G, Orlic D, Corvaja N, Airoldi F, Chieffo A, Spanos V, et al. Incidence, predictors, in‐hospital, and late outcomes of coronary artery perforations. The American Journal of Cardiology 2004;93(2):213‐6.
College Station, TX: StataCorp LP. StataCorp. 2015. Stata Statistical Software: Release 14 . College Station, TX: StataCorp LP, 2015.
Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338:b2393. [PUBMED: 19564179]
Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, et al. Outcomes associated with drug‐eluting and bare‐metal stents: a collaborative network meta‐analysis. Lancet 2007;370(9591):937‐48. [PUBMED: 17869634]
Stevenson WG, Linssen GC, Havenith MG, Brugada P, Wellens HJ. The spectrum of death after myocardial infarction: a necropsy study. American Heart Journal 1989;118(6):1182‐8.
Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer‐based, paclitaxel‐eluting stent in patients with coronary artery disease. The New England Journal of Medicine 2004;350(3):221‐31. [PUBMED: 14724301]
Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. One‐year clinical results with the slow‐release, polymer‐based, paclitaxel‐eluting TAXUS stent: the TAXUS‐IV trial. Circulation 2004;109(16):1942‐7. [PUBMED: 15078803]
Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, et al. Everolimus‐eluting versus paclitaxel‐eluting stents in coronary artery disease. The New England Journal of Medicine 2010;362(18):1663‐74.
Suh HS, Song HJ, Choi JE, Jang EJ, Son HJ, Lee SM, et al. Drug‐eluting stents versus bare‐metal stents in acute myocardial infarction: a systematic review and meta‐analysis. International Journal of Technology Assessment in Health Care 2011;27(1):11‐22. [PUBMED: 21262083]
Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data. Statistics in Medicine 2004;23(9):1351‐75. [PUBMED: 15116347]
Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, et al. Initial and 6‐month results of biodegradable poly‐i‐lactic acid coronary stents in humans. Circulation 2000;102(4):399‐404.
Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, et al. Prevalence of depression in survivors of acute myocardial infarction. Journal of General Internal Medicine 2006;21(1):30‐8.
Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses?. International Journal of Epidemiology 2009;38(1):276‐86.
Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for Trial Sequential Analysis (TSA). www.ctu.dk/tsa/files/tsa_manual.pdf (accessed 15 May 2015).
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Global Heart 2012;7(4):275‐95. [PUBMED: 25689940]
Turner RM, Bird SM, Higgins JP. The impact of study size on meta‐analyses: examination of underpowered studies in Cochrane reviews. PloS One 2013;8(3):e59202. [PUBMED: 23544056]
Turpie AG. Burden of disease: medical and economic impact of acute coronary syndromes. The American Journal of Managed Care 2006;12(16 Suppl):S430‐4.
Ware JE, Sherbourne CD. The MOS 36‐item short‐form health survey (SF‐36). I. Conceptual framework and item selection. Medical Care 1992;30(6):473‐83.
Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology 2008;61(1):64‐75.
Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology 2009;9:86.
White HD, Chew DP. Acute myocardial infarction. Lancet 2008;372(9638):570‐84.
World Health Organization (WHO). Cardiovascular diseases. www.who.int/cardiovascular_diseases/en/ (accessed 27 January 2015).
Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio‐Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal 2014;35(37):2541‐619.
Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ 2008;336(7644):601‐5.
Wyrwich KW, Spertus JA, Kroenke K, Tierney WM, Babu AN, Wolinsky FD, Heart Disease Expert Panel. Clinically important differences in health status for patients with heart disease: an expert consensus panel report. American Heart Journal 2004;147(4):615‐22.
Zheng F, Xing S, Gong Z, Xing Q. Five‐year outcomes for first generation drug‐eluting stents versus bare‐metal stents in patients with ST‐segment elevation myocardial infarction: a meta‐analysis of randomised controlled trials. Heart, Lung & Circulation 2014;23(6):542‐8. [PUBMED: 24529648]
